Tivic Health Has Partnered With Fletcher Spaght, To Accelerate Development Of Its Commercial Strategy For Non-Invasive Cervical Vagus Nerve Stimulation
Portfolio Pulse from Benzinga Newsdesk
Tivic Health has partnered with Fletcher Spaght to enhance its commercial strategy for non-invasive cervical vagus nerve stimulation. The global market for vagus nerve stimulation is expected to grow significantly, with Tivic Health targeting a rapidly expanding segment.
September 17, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tivic Health has partnered with Fletcher Spaght to accelerate its commercial strategy for non-invasive cervical vagus nerve stimulation. This partnership aims to capitalize on the rapidly growing market for vagus nerve stimulation.
The partnership with Fletcher Spaght is likely to enhance Tivic Health's commercial strategy, positioning it well in a market projected to grow significantly. This strategic move could positively impact Tivic Health's market presence and financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100